Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Pharmaceutical Statistics
|
January 26, 2007
A two-stage phase II trial design utilizing both primary and secondary endpoints
Xun Lin, Randy Allred, Glen Andrews
Molecular Pharmacology
|
November 29, 2007
An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5
Glen Andrews, Carolyn Jones, Keith A Wreggett
Science Signaling
|
July 8, 2010
Zinc bells rang in Jerusalem!
Michal Hershfinkel, Elias Aizenman, Glen Andrews, et al.
NPJ Primary Care Respiratory Medicine
|
October 26, 2018
Prospective observational cohort study of symptom control prediction in paediatric asthma by using the Royal College of Physicians three questions
Glen Andrews, David K H Lo, Matthew Richardson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
January 7, 2011
Knockout of Zn transporters Zip-1 and Zip-3 attenuates seizure-induced CA1 neurodegeneration
Jing Qian, Kaiping Xu, Jong Yoo, et al.
The Journal of Biological Chemistry
|
April 1, 2004
Zinc-stimulated endocytosis controls activity of the mouse ZIP1 and ZIP3 zinc uptake transporters
Fudi Wang, Jodi Dufner-Beattie, Byung-Eun Kim, et al.
Human Molecular Genetics
|
January 8, 2004
Acrodermatitis enteropathica mutations affect transport activity, localization and zinc-responsive trafficking of the mouse ZIP4 zinc transporter
Fudi Wang, Byung-Eun Kim, Jodi Dufner-Beattie, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 1, 2011
Design of novel and potent cPLA2α inhibitors containing an α-methyl-2-ketothiazole as a metabolically stable serine trap
Antonio Mete, Glen Andrews, Mike Bernstein, et al.
Journal of Medicinal Chemistry
|
May 3, 2014
Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD
Chris De Savi, Rhona J Cox, Daniel J Warner, et al.
ACS Medicinal Chemistry Letters
|
September 27, 2017
Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists
Nicholas Kindon, Glen Andrews, Andrew Baxter, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Pharmaceutical Statistics
|
January 26, 2007
A two-stage phase II trial design utilizing both primary and secondary endpoints
Xun Lin, Randy Allred, Glen Andrews
Molecular Pharmacology
|
November 29, 2007
An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5
Glen Andrews, Carolyn Jones, Keith A Wreggett
Science Signaling
|
July 8, 2010
Zinc bells rang in Jerusalem!
Michal Hershfinkel, Elias Aizenman, Glen Andrews, et al.
NPJ Primary Care Respiratory Medicine
|
October 26, 2018
Prospective observational cohort study of symptom control prediction in paediatric asthma by using the Royal College of Physicians three questions
Glen Andrews, David K H Lo, Matthew Richardson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
January 7, 2011
Knockout of Zn transporters Zip-1 and Zip-3 attenuates seizure-induced CA1 neurodegeneration
Jing Qian, Kaiping Xu, Jong Yoo, et al.
The Journal of Biological Chemistry
|
April 1, 2004
Zinc-stimulated endocytosis controls activity of the mouse ZIP1 and ZIP3 zinc uptake transporters
Fudi Wang, Jodi Dufner-Beattie, Byung-Eun Kim, et al.
Human Molecular Genetics
|
January 8, 2004
Acrodermatitis enteropathica mutations affect transport activity, localization and zinc-responsive trafficking of the mouse ZIP4 zinc transporter
Fudi Wang, Byung-Eun Kim, Jodi Dufner-Beattie, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 1, 2011
Design of novel and potent cPLA2α inhibitors containing an α-methyl-2-ketothiazole as a metabolically stable serine trap
Antonio Mete, Glen Andrews, Mike Bernstein, et al.
Journal of Medicinal Chemistry
|
May 3, 2014
Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD
Chris De Savi, Rhona J Cox, Daniel J Warner, et al.
ACS Medicinal Chemistry Letters
|
September 27, 2017
Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists
Nicholas Kindon, Glen Andrews, Andrew Baxter, et al.
Page
of 2